← All runs · Coder view for P15
Replay LRUN-00015 criteria library
Live recomputation (nothing written): identical hash
- Stored replay hash
7ec5fd4e26dc2335f0611de06df1a6a736b9715c47b7517905d5bb11adfbba19- Recomputed replay hash
7ec5fd4e26dc2335f0611de06df1a6a736b9715c47b7517905d5bb11adfbba19- Measurement-side replay hash
daa49e0bba824e02db22e6b083f44c7d0733c1565456e2db9c4b2decf0a2138e- Inputs intact
- yes
- Engine and default set
- library-engine 1.0 · library_default_set@1.0
- Trigger
- seed · Fri Nov 13, 2026 04:55 PM · after kidney check RUN-00015
| Definition | File sha256 |
|---|---|
ada2026_diabetes@1.0 | e6a402d238eabf94… |
ada2026_hypoglycaemia@1.0 | 46bd77ec8ba977e0… |
ada2026_prediabetes@1.0 | af2c23fe63c64897… |
aha2018_severe_hypercholesterolaemia@1.0 | 07ac207b49ba33e7… |
atp3_ldl@1.0 | 984f30f535df92c4… |
berlin2012_ards_pf@1.0 | f6d9be0dcd8cd4f8… |
cdc_adult_bmi@1.0 | 14a2ac45496eea31… |
esc2024_office_bp@1.0 | f507c6c22d66becc… |
ese2014_hyponatraemia@1.0 | 80cb82e9b02b3fc8… |
global2024_ards_intubated_pf@1.0 | 64bbc3f7fa5c4c0c… |
gold2026_copd_airflow@1.0 | 5fe646eb07866c22… |
nhlbi_bp_categories@1.0 | 17c10323497aaed9… |
sepsis3_septic_shock_lactate@1.0 | 349d2d1b41e02f6a… |
uhf2021_hf_ef_category@1.0 | d056531cd58ff1c1… |
ukka2026_hyperkalaemia@1.0 | 52e59d35a9e19548… |
who1994_osteoporosis@1.0 | 285f666b9d1cbe75… |
who2020_iron_deficiency_ferritin@1.0 | 1cf50051fb66f445… |
who2024_anaemia@1.0 | f2ece42ed4d73490… |
who_adult_bmi@1.0 | de4e41b72636521d… |
Stored inputs (exactly what the definitions read)
{
"as_of": "2026-11-13T16:55:00-05:00",
"context": {},
"encounter": {
"admit_dt": "2026-11-11T14:00:00-05:00",
"discharge_dt": null,
"encounter_id": "KE-P15",
"setting": "inpatient"
},
"entered": [],
"measurements": [
{
"analyte": "potassium_serum",
"flags": [],
"measurement_id": "LM-P15-01",
"ref_high": null,
"ref_low": null,
"time": "2026-11-11T15:00:00-05:00",
"unit": "mmol/L",
"value": 5.1
},
{
"analyte": "lactate_serum",
"flags": [],
"measurement_id": "LM-P15-03",
"ref_high": null,
"ref_low": null,
"time": "2026-11-11T15:10:00-05:00",
"unit": "mmol/L",
"value": 2.6
},
{
"analyte": "potassium_serum",
"flags": [],
"measurement_id": "LM-P15-02",
"ref_high": null,
"ref_low": null,
"time": "2026-11-12T15:00:00-05:00",
"unit": "mmol/L",
"value": 5.8
}
],
"note": {
"note_id": "KN-P15-1",
"reading": {
"default_status": "silent",
"families": {
"blood_pressure": {
"faults": [],
"spans": [],
"status": "silent"
},
"bmi": {
"faults": [],
"spans": [],
"status": "silent"
},
"bone_density": {
"faults": [],
"spans": [],
"status": "silent"
},
"copd_airflow": {
"faults": [],
"spans": [],
"status": "silent"
},
"diabetes": {
"faults": [],
"spans": [],
"status": "silent"
},
"ferritin": {
"faults": [],
"spans": [],
"status": "silent"
},
"haemoglobin": {
"faults": [],
"spans": [],
"status": "silent"
},
"heart_failure_ef": {
"faults": [],
"spans": [],
"status": "silent"
},
"hypoglycaemia": {
"faults": [],
"spans": [],
"status": "silent"
},
"lactate": {
"faults": [],
"spans": [],
"status": "silent"
},
"ldl": {
"faults": [],
"spans": [],
"status": "silent"
},
"oxygenation": {
"faults": [],
"spans": [],
"status": "silent"
},
"potassium": {
"faults": [],
"spans": [],
"status": "silent"
},
"prediabetes": {
"faults": [],
"spans": [],
"status": "silent"
},
"sodium": {
"faults": [],
"spans": [],
"status": "silent"
}
},
"lexicon": "library-lexicon 1.0",
"model_status": "ok",
"reader": "lexicon+model",
"text_sha256": "17374e4a7bafa0ca5f9fc14a4ea7f0423fbc108c071a57b93371b792a5cbbc2a"
}
},
"patient": {
"birth_date": "1950-11-16",
"patient_id": "P15",
"sex": "F"
},
"settings": {
"ctcae_grading": false
}
}Stored output
{
"coder_rows": [
{
"assessment": "not_stated",
"assessment_label": "The record supports it; neither stated in the note nor entered",
"category": "mild",
"category_label": "Mild hyperkalaemia (5.5\u20135.9 mmol/L)",
"condition": "Hyperkalaemia",
"definition": "ukka2026_hyperkalaemia@1.0",
"detail": "",
"entered": [],
"expected_codes": [],
"family": "potassium",
"note": {
"mentions": [],
"quotes": [],
"status": "silent"
},
"open": true,
"query_available": true,
"reasons": [],
"specificity_distinguished": null,
"state": "met",
"supported": {
"category": "mild",
"earlier": false,
"time": "2026-11-13T16:55:00-05:00",
"values": [
{
"analyte": "potassium_serum",
"measurement_id": "LM-P15-02",
"time": "2026-11-12T15:00:00-05:00",
"unit": "mmol/L",
"value": 5.8
}
]
},
"tier": "measured",
"values": [
{
"analyte": "potassium_serum",
"measurement_id": "LM-P15-02",
"time": "2026-11-12T15:00:00-05:00",
"unit": "mmol/L",
"value": 5.8
}
]
},
{
"assessment": "cannot_assess",
"assessment_label": "Cannot be assessed",
"category": "above",
"category_label": "Lactate >2 mmol/L (18 mg/dL): the Sepsis-3 septic-shock lactate criterion is met",
"condition": "Septic shock (lactate component)",
"definition": "sepsis3_septic_shock_lactate@1.0",
"detail": "judgement tier: the record shows these values; the condition needs clinical judgement",
"entered": [],
"expected_codes": [],
"family": "lactate",
"note": {
"mentions": [],
"quotes": [],
"status": "silent"
},
"open": false,
"query_available": false,
"reasons": [],
"specificity_distinguished": null,
"state": "met",
"supported": {
"category": "above",
"earlier": false,
"time": "2026-11-13T16:55:00-05:00",
"values": [
{
"analyte": "lactate_serum",
"measurement_id": "LM-P15-03",
"time": "2026-11-11T15:10:00-05:00",
"unit": "mmol/L",
"value": 2.6
}
]
},
"tier": "judgement",
"values": [
{
"analyte": "lactate_serum",
"measurement_id": "LM-P15-03",
"time": "2026-11-11T15:10:00-05:00",
"unit": "mmol/L",
"value": 2.6
}
]
}
],
"config": "library_default_set@1.0",
"definitions": {
"ada2026_diabetes@1.0": "e6a402d238eabf948e24e0c1a768094b2a8eab1534d0208b533bcf624a7c56a7",
"ada2026_hypoglycaemia@1.0": "46bd77ec8ba977e0a1f201d4ef02d934accd0ab454ed12ef6d6c7f189f56a9a0",
"ada2026_prediabetes@1.0": "af2c23fe63c64897f2f72242153b81971f32dba4ad55ac279abf2a2991d0e112",
"aha2018_severe_hypercholesterolaemia@1.0": "07ac207b49ba33e7c341f45bd1e6652460273e35b8ccb6e9882ce4e14506f24b",
"atp3_ldl@1.0": "984f30f535df92c4f68bcb7331a079e98e17980f6cba9e3e3ca40f3dda5eee03",
"berlin2012_ards_pf@1.0": "f6d9be0dcd8cd4f86bcc8ecd1bd12854e408cc9e25db8f136564584b9c202d77",
"cdc_adult_bmi@1.0": "14a2ac45496eea318a30ab4841e1635efe3b8051355ff920c39b471475a3fa80",
"esc2024_office_bp@1.0": "f507c6c22d66beccef76705f376bfcd942d7852733727916e8e70c9b78ef9f4c",
"ese2014_hyponatraemia@1.0": "80cb82e9b02b3fc8c2af10544ac52733b115d2a2436f871ddd9f56276c4fd90b",
"global2024_ards_intubated_pf@1.0": "64bbc3f7fa5c4c0c445d87883b20d22351bdb59ba670062bb4807a1bc924b89f",
"gold2026_copd_airflow@1.0": "5fe646eb07866c220b55269655e680c559148e99cda65c6dd5faf3198d549e93",
"nhlbi_bp_categories@1.0": "17c10323497aaed97bf08b4f9db27dc328068eccd4fd0fccf11af416207b76d3",
"sepsis3_septic_shock_lactate@1.0": "349d2d1b41e02f6a8ad26bd1df917967ec1b78539948f165c14d29e427e8d6aa",
"uhf2021_hf_ef_category@1.0": "d056531cd58ff1c18dba497a2ed8f8373ed9f9583c3a072a8b525d6a67eb61c3",
"ukka2026_hyperkalaemia@1.0": "52e59d35a9e19548932d6bf551f322dbcd68e1e05aab0ba68e346d81eaf35c73",
"who1994_osteoporosis@1.0": "285f666b9d1cbe759d9b827772316840002f5b2439b71ed10aedcb437a089014",
"who2020_iron_deficiency_ferritin@1.0": "1cf50051fb66f445ab663519fb2ec6e5d60dc73f96a9ee96a86becd424e10ad1",
"who2024_anaemia@1.0": "f2ece42ed4d7349094e3066f58b4bd9aece49873b33aa458945093e29ad4cede",
"who_adult_bmi@1.0": "de4e41b72636521df138a3846f673cb8d1f1bb3695ace4d31b592352a719668e"
},
"engine": "library-engine 1.0",
"findings": [
{
"checks": [
"contradiction",
"not_stated"
],
"citation": {
"code_reference": {
"categories": [
{
"billable_codes_fy2027": 14,
"category": "E87",
"cms_hcc_v28": {
"codes_mapping": 0,
"hccs": []
},
"ms_drg_v44": {
"codes_with_cc": 8,
"codes_with_mcc": 0,
"summary": "some codes in this category are CC"
},
"note": null,
"source": "data/code_reference_fy2027.json (CDC/NCHS ICD-10-CM FY2027 order file; CMS FY2027 Tables 6I/6J; CMS 2027 Initial ICD-10-CM Mappings)",
"specificity_distinguished": "E87.5 hyperkalemia (one code; no severity axis)",
"title": "Other disorders of fluid, electrolyte and acid-base balance"
}
],
"icd10cm_fiscal_year": "FY2027 (effective 2026-10-01)",
"null_reason": null,
"use": "reference for coders \u2014 the software never assigns or suggests a code"
},
"condition": "Hyperkalaemia",
"confirmation": null,
"contested": {
"is_contested": true,
"why": "The guideline itself says 'There is no universally accepted definition of hyperkalaemia'; it adopts the ERC threshold of 5.5 mmol/L. CTCAE grades differ (see ctcae6_hyperkalaemia)."
},
"edition": {
"checked_at": "https://www.ukkidney.org/sites/default/files/documents/FINAL%20VERSION%20-%20UKKA%20CLINICAL%20PRACTICE%20GUIDELINE%20-%20MANAGEMENT%20OF%20HYPERKALAEMIA%20IN%20ADULTS%20-%20UPDATED%20JULY%202026_0.pdf",
"checked_on": "2026-11-14",
"edition": "updated July 2026",
"is_current": true,
"note": "Document front page: original July 2020, updated October 2023, updated July 2026, review date October 2026. The July 2026 file is the newest found on the association's site.",
"year": 2026
},
"id": "ukka2026_hyperkalaemia",
"inputs": [
{
"analyte": "potassium_serum",
"key": "k",
"select": "latest",
"source_units": [
"mmol/L"
],
"unit": "mmol/L"
}
],
"interpretation_notes": [
"Adjacent printed ranges that differ by one reporting unit (for example '120\u2013129' then '130\u2013139', or '5.5-5.9' then '6.0-6.4') are read as half-open intervals [lower, next lower), so a value between them (129.5, 5.95) falls in the lower band. Only a genuine gap in the printed ranges returns not assessable.",
"The introduction once writes 'severe hyperkalaemia (K+ > 6.5 mmol/l)' but the classification sentence and every guideline statement use '\u2265 6.5'; \u22656.5 is encoded.",
"The most recent potassium up to as_of is used."
],
"kind": "executable definition",
"not_encoded": [
"Pseudohyperkalaemia (guideline 15.3: haemolysis, delayed analysis, sampling technique) is not detected; a haemolysed sample is graded like any other unless the sender withholds it.",
"Acute versus chronic (persistent) hyperkalaemia and the guideline's repeat-testing intervals (guidelines 1.2.1-1.2.3) are not encoded.",
"ECG changes and clinical context are not assessed."
],
"population": "adults (the guideline title: 'in Adults')",
"primary_source": {
"accessed": "2026-11-14",
"body": "UK Kidney Association",
"edition": "updated July 2026",
"locator": "Introduction, document page 9 (PDF page 10)",
"quote": "It is further classified by severity into mild (5.5-5.9 mmol/l), moderate (6.0-6.4 mmol/l) or severe (\u2265 6.5 mmol/l).",
"title": "Clinical Practice Guidelines: Treatment of Acute Hyperkalaemia in Adults",
"url": "https://www.ukkidney.org/sites/default/files/documents/FINAL%20VERSION%20-%20UKKA%20CLINICAL%20PRACTICE%20GUIDELINE%20-%20MANAGEMENT%20OF%20HYPERKALAEMIA%20IN%20ADULTS%20-%20UPDATED%20JULY%202026_0.pdf",
"year": 2026
},
"second_source": {
"accessed": "2026-11-14",
"body": "National Cancer Institute, Cancer Therapy Evaluation Program (U.S. Department of Health and Human Services)",
"edition": "v6.0",
"locator": "PDF page 177, term 'Hyperkalemia' (published July 22, 2025)",
"quote": "Grade 1: >ULN - 5.5 mmol/L. Grade 2: >5.5 - 6.0 mmol/L ... Grade 4: >7.0 mmol/L",
"title": "Common Terminology Criteria for Adverse Events (CTCAE) v6.0 (MedDRA 28.0)",
"url": "https://dctd.cancer.gov/research/ctep-trials/for-sites/adverse-events/ctcae-v6.pdf",
"year": 2025
},
"second_source_note": "CTCAE uses different bands; the UKKA text states its 5.5 mmol/L threshold comes from the European Resuscitation Council guideline, which was not opened.",
"second_source_status": "disagrees",
"status": "draft \u2014 requires clinical and coding review",
"thresholds": [
{
"categories": [
{
"condition_present": true,
"id": "severe",
"label": "Severe hyperkalaemia (\u22656.5 mmol/L)",
"rule": "k \u2265 6.5 mmol/L"
},
{
"condition_present": true,
"id": "moderate",
"label": "Moderate hyperkalaemia (6.0\u20136.4 mmol/L)",
"rule": "k \u2265 6 mmol/L and k < 6.5 mmol/L"
},
{
"condition_present": true,
"id": "mild",
"label": "Mild hyperkalaemia (5.5\u20135.9 mmol/L)",
"rule": "k \u2265 5.5 mmol/L and k < 6 mmol/L"
},
{
"condition_present": false,
"id": "below_threshold",
"label": "Below 5.5 mmol/L",
"rule": "k < 5.5 mmol/L"
}
],
"variant": "all",
"variant_label": "all patients in the population"
}
],
"tier": 1,
"title": "Hyperkalaemia and its severity (UK Kidney Association, July 2026 update)",
"version": "1.0"
},
"contested": true,
"contested_note": "The guideline itself says 'There is no universally accepted definition of hyperkalaemia'; it adopts the ERC threshold of 5.5 mmol/L. CTCAE grades differ (see ctcae6_hyperkalaemia).",
"definition": "ukka2026_hyperkalaemia@1.0",
"direction": "UNDER",
"draft": true,
"family": "potassium",
"family_order": 2,
"id": "ukka2026_hyperkalaemia",
"measurement": {
"adjustments": [],
"alternatives": [],
"any_history": true,
"category": "mild",
"category_label": "Mild hyperkalaemia (5.5\u20135.9 mmol/L)",
"clinician_label": "'mild' band (5.5 to 5.9 mmol/L)",
"condition_threshold": "'severe' band (6.5 mmol/L or more) (potassium \u2265 6.5 mmol/L); 'moderate' band (6.0 to 6.4 mmol/L) (potassium \u2265 6 mmol/L and potassium < 6.5 mmol/L); 'mild' band (5.5 to 5.9 mmol/L) (potassium \u2265 5.5 mmol/L and potassium < 6 mmol/L)",
"confirmation": null,
"contested": true,
"contested_note": "The guideline itself says 'There is no universally accepted definition of hyperkalaemia'; it adopts the ERC threshold of 5.5 mmol/L. CTCAE grades differ (see ctcae6_hyperkalaemia).",
"definition": "ukka2026_hyperkalaemia@1.0",
"edition_current": true,
"family": "potassium",
"has_data": true,
"id": "ukka2026_hyperkalaemia",
"missing_context": [],
"notes": [],
"reason_code": null,
"reasons": [],
"result": "met",
"scan": [
{
"category": "below_threshold",
"confirmed": true,
"result": "criteria_not_met",
"time": "2026-11-11T15:00:00-05:00",
"values": [
{
"analyte": "potassium_serum",
"measurement_id": "LM-P15-01",
"time": "2026-11-11T15:00:00-05:00",
"unit": "mmol/L",
"value": 5.1
}
]
},
{
"category": "mild",
"confirmed": true,
"result": "met",
"time": "2026-11-12T15:00:00-05:00",
"values": [
{
"analyte": "potassium_serum",
"measurement_id": "LM-P15-02",
"time": "2026-11-12T15:00:00-05:00",
"unit": "mmol/L",
"value": 5.8
}
]
}
],
"state": "met",
"status_text": "draft \u2014 requires clinical and coding review",
"supported": {
"category": "mild",
"earlier": false,
"time": "2026-11-13T16:55:00-05:00",
"values": [
{
"analyte": "potassium_serum",
"measurement_id": "LM-P15-02",
"time": "2026-11-12T15:00:00-05:00",
"unit": "mmol/L",
"value": 5.8
}
]
},
"threshold": "potassium \u2265 5.5 mmol/L and potassium < 6 mmol/L",
"tier": "measured",
"values": [
{
"analyte": "potassium_serum",
"measurement_id": "LM-P15-02",
"time": "2026-11-12T15:00:00-05:00",
"unit": "mmol/L",
"value": 5.8
}
],
"variant": "all",
"version": "1.0",
"window": {
"days": 14,
"from": "2026-10-30T21:55:00",
"n": 2,
"to": "2026-11-13T21:55:00"
},
"window_assessable": true,
"window_met": true
},
"note": {
"faults": [],
"spans": [],
"status": "silent"
},
"optional_set": null,
"priority": [
2,
2,
"potassium"
],
"status_text": "draft \u2014 requires clinical and coding review",
"tier": "measured",
"topic": "Potassium",
"version": "1.0",
"why": ""
},
{
"checks": [
"judgement_tier"
],
"citation": {
"code_reference": {
"categories": [],
"icd10cm_fiscal_year": "FY2027 (effective 2026-10-01)",
"null_reason": "A lactate value is a laboratory component, not a condition; sepsis and septic shock codes (A40-A41, R65.2-) depend on clinical documentation (see catalogue entry sepsis3_sepsis_and_septic_shock).",
"use": "reference for coders \u2014 the software never assigns or suggests a code"
},
"condition": "Septic shock (lactate component)",
"confirmation": null,
"contested": {
"is_contested": false,
"why": "The CMS SEP-1 measure and the Surviving Sepsis Campaign use lactate thresholds for other purposes (for example \u22654 mmol/L); those documents were not opened for this entry."
},
"edition": {
"checked_at": "https://pmc.ncbi.nlm.nih.gov/articles/PMC4968574/",
"checked_on": "2026-11-14",
"edition": "Sepsis-3 (2016)",
"is_current": true,
"note": "Sepsis-3 remains the consensus definition indexed; no Sepsis-4 definition was found in Europe PMC on 2026-11-14.",
"year": 2016
},
"id": "sepsis3_septic_shock_lactate",
"inputs": [
{
"analyte": "lactate_serum",
"key": "lac",
"select": "latest",
"source_units": [
"mmol/L",
"mg/dL"
],
"unit": "mmol/L"
}
],
"interpretation_notes": [
"Sepsis-3 prints 2 mmol/L as 18 mg/dL; each unit is compared against its own printed number."
],
"kind": "executable definition",
"not_encoded": [
"Septic shock also requires sepsis (suspected or documented infection with an acute increase in SOFA \u22652), persisting hypotension requiring vasopressors to maintain MAP \u226565 mm Hg, and adequate volume resuscitation; none of these is assessed. This entry never says septic shock is present.",
"Timing of the lactate relative to resuscitation is not checked; the most recent value is used."
],
"population": "any patient (the source states no population limit)",
"primary_source": {
"accessed": "2026-11-14",
"body": "Society of Critical Care Medicine and European Society of Intensive Care Medicine task force (JAMA 2016;315:801-810)",
"edition": "2016",
"locator": "Box 3 'New Terms and Definitions'",
"quote": "persisting hypotension requiring vasopressors to maintain MAP \u226565 mm Hg and having a serum lactate level >2 mmol/L (18mg/dL) despite adequate volume resuscitation",
"title": "The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)",
"url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC4968574/",
"year": 2016
},
"second_source": null,
"second_source_note": "No independent second source was opened for this threshold.",
"second_source_status": "not found",
"status": "draft \u2014 requires clinical and coding review",
"thresholds": [
{
"categories": [
{
"condition_present": true,
"id": "above",
"label": "Lactate >2 mmol/L (18 mg/dL): the Sepsis-3 septic-shock lactate criterion is met",
"rule": "lac > 2 mmol/L / 18 mg/dL"
},
{
"condition_present": false,
"id": "not_above",
"label": "Lactate 2 mmol/L or below",
"rule": "lac \u2264 2 mmol/L / 18 mg/dL"
}
],
"variant": "all",
"variant_label": "all patients in the population"
}
],
"tier": 1,
"title": "Serum lactate above the Sepsis-3 septic-shock threshold (numeric component only)",
"version": "1.0"
},
"contested": false,
"contested_note": "The CMS SEP-1 measure and the Surviving Sepsis Campaign use lactate thresholds for other purposes (for example \u22654 mmol/L); those documents were not opened for this entry.",
"definition": "sepsis3_septic_shock_lactate@1.0",
"direction": "JUDGEMENT",
"draft": true,
"family": "lactate",
"family_order": 13,
"id": "sepsis3_septic_shock_lactate",
"measurement": {
"adjustments": [],
"alternatives": [],
"any_history": true,
"category": "above",
"category_label": "Lactate >2 mmol/L (18 mg/dL): the Sepsis-3 septic-shock lactate criterion is met",
"clinician_label": "lactate above 2 mmol/L",
"condition_threshold": "lactate above 2 mmol/L (lactate > 2 mmol/L)",
"confirmation": null,
"contested": false,
"contested_note": "The CMS SEP-1 measure and the Surviving Sepsis Campaign use lactate thresholds for other purposes (for example \u22654 mmol/L); those documents were not opened for this entry.",
"definition": "sepsis3_septic_shock_lactate@1.0",
"edition_current": true,
"family": "lactate",
"has_data": true,
"id": "sepsis3_septic_shock_lactate",
"missing_context": [],
"notes": [],
"reason_code": null,
"reasons": [],
"result": "met",
"scan": [
{
"category": "above",
"confirmed": true,
"result": "met",
"time": "2026-11-11T15:10:00-05:00",
"values": [
{
"analyte": "lactate_serum",
"measurement_id": "LM-P15-03",
"time": "2026-11-11T15:10:00-05:00",
"unit": "mmol/L",
"value": 2.6
}
]
}
],
"state": "met",
"status_text": "draft \u2014 requires clinical and coding review",
"supported": {
"category": "above",
"earlier": false,
"time": "2026-11-13T16:55:00-05:00",
"values": [
{
"analyte": "lactate_serum",
"measurement_id": "LM-P15-03",
"time": "2026-11-11T15:10:00-05:00",
"unit": "mmol/L",
"value": 2.6
}
]
},
"threshold": "lactate > 2 mmol/L",
"tier": "judgement",
"values": [
{
"analyte": "lactate_serum",
"measurement_id": "LM-P15-03",
"time": "2026-11-11T15:10:00-05:00",
"unit": "mmol/L",
"value": 2.6
}
],
"variant": "all",
"version": "1.0",
"window": {
"days": 7,
"from": "2026-11-06T21:55:00",
"n": 1,
"to": "2026-11-13T21:55:00"
},
"window_assessable": true,
"window_met": true
},
"note": {
"faults": [],
"spans": [],
"status": "silent"
},
"optional_set": null,
"priority": [
5,
13,
"lactate"
],
"status_text": "draft \u2014 requires clinical and coding review",
"tier": "judgement",
"topic": "Lactate",
"version": "1.0",
"why": ""
},
{
"checks": [
"contradiction",
"not_stated"
],
"citation": null,
"contested": true,
"contested_note": "Cut-offs are 5th percentiles of mostly higher-income populations (WHO's own remark); the men's 130 g/L cut-off and severity percentages were debated by the guideline group; CTCAE and laboratory reference ranges use other limits; older adults (>65) are not covered.",
"definition": "who2024_anaemia@1.0",
"direction": "NOT_ASSESSED",
"draft": true,
"family": "haemoglobin",
"family_order": 0,
"id": "who2024_anaemia",
"measurement": {
"adjustments": [],
"alternatives": [],
"any_history": false,
"category": null,
"category_label": null,
"clinician_label": null,
"condition_threshold": "'severe' band (haemoglobin < 70 g/L); 'moderate' band (haemoglobin \u2265 70 g/L and haemoglobin < 100 g/L); 'mild' band (haemoglobin \u2265 100 g/L and haemoglobin < 110 g/L)",
"confirmation": null,
"contested": true,
"contested_note": "Cut-offs are 5th percentiles of mostly higher-income populations (WHO's own remark); the men's 130 g/L cut-off and severity percentages were debated by the guideline group; CTCAE and laboratory reference ranges use other limits; older adults (>65) are not covered.",
"definition": "who2024_anaemia@1.0",
"edition_current": true,
"family": "haemoglobin",
"has_data": false,
"id": "who2024_anaemia",
"missing_context": [],
"notes": [],
"reason_code": "no_value",
"reasons": [
"outside the population the source defines: individuals aged 6 months to 65 years (Table 2 covers no other ages); pregnancy by trimester"
],
"result": "not_assessable",
"scan": [],
"state": "no_data",
"status_text": "draft \u2014 requires clinical and coding review",
"supported": null,
"threshold": null,
"tier": "measured",
"values": [],
"variant": null,
"version": "1.0",
"window": {
"days": 30,
"from": "2026-10-14T21:55:00",
"n": 0,
"to": "2026-11-13T21:55:00"
},
"window_assessable": false,
"window_met": false
},
"note": {
"faults": [],
"spans": [],
"status": "silent"
},
"optional_set": null,
"priority": [
8,
0,
"haemoglobin"
],
"status_text": "draft \u2014 requires clinical and coding review",
"tier": "measured",
"topic": "Haemoglobin",
"version": "1.0",
"why": "no measurement in the window"
},
{
"checks": [
"contradiction",
"not_stated"
],
"citation": null,
"contested": false,
"contested_note": "The <135 mmol/L definition is widely shared; CTCAE uses the laboratory LLN instead.",
"definition": "ese2014_hyponatraemia@1.0",
"direction": "NOT_ASSESSED",
"draft": true,
"family": "sodium",
"family_order": 1,
"id": "ese2014_hyponatraemia",
"measurement": {
"adjustments": [],
"alternatives": [],
"any_history": false,
"category": null,
"category_label": null,
"clinician_label": null,
"condition_threshold": "below 135 mmol/L (sodium < 135 mmol/L)",
"confirmation": null,
"contested": false,
"contested_note": "The <135 mmol/L definition is widely shared; CTCAE uses the laboratory LLN instead.",
"definition": "ese2014_hyponatraemia@1.0",
"edition_current": null,
"family": "sodium",
"has_data": false,
"id": "ese2014_hyponatraemia",
"missing_context": [],
"notes": [],
"reason_code": "no_value",
"reasons": [
"no usable sodium_serum measurement"
],
"result": "not_assessable",
"scan": [],
"state": "no_data",
"status_text": "draft \u2014 requires clinical and coding review",
"supported": null,
"threshold": null,
"tier": "measured",
"values": [],
"variant": null,
"version": "1.0",
"window": {
"days": 14,
"from": "2026-10-30T21:55:00",
"n": 0,
"to": "2026-11-13T21:55:00"
},
"window_assessable": false,
"window_met": false
},
"note": {
"faults": [],
"spans": [],
"status": "silent"
},
"optional_set": null,
"priority": [
8,
1,
"sodium"
],
"status_text": "draft \u2014 requires clinical and coding review",
"tier": "measured",
"topic": "Sodium",
"version": "1.0",
"why": "no measurement in the window"
},
{
"checks": [
"contradiction",
"not_stated"
],
"citation": null,
"contested": false,
"contested_note": "ADA thresholds match long-standing WHO thresholds for A1C and FPG, but WHO's current text was not opened; the A1C criterion is less sensitive in some populations (ADA text).",
"definition": "ada2026_diabetes@1.0",
"direction": "NOT_ASSESSED",
"draft": true,
"family": "diabetes",
"family_order": 3,
"id": "ada2026_diabetes",
"measurement": {
"adjustments": [],
"alternatives": [],
"any_history": false,
"category": null,
"category_label": null,
"clinician_label": null,
"condition_threshold": "two results at or above the diagnostic thresholds (number of qualifying results \u2265 2); random glucose 200 mg/dL or more with typical symptoms (random glucose \u2265 200 mg/dL and a recorded clinical item); one result at or above a diagnostic threshold (number of qualifying results \u2265 1)",
"confirmation": null,
"contested": false,
"contested_note": "ADA thresholds match long-standing WHO thresholds for A1C and FPG, but WHO's current text was not opened; the A1C criterion is less sensitive in some populations (ADA text).",
"definition": "ada2026_diabetes@1.0",
"edition_current": true,
"family": "diabetes",
"has_data": false,
"id": "ada2026_diabetes",
"missing_context": [],
"notes": [],
"reason_code": "no_value",
"reasons": [
"needed to decide whether the definition applies: context 'pregnant' not provided"
],
"result": "not_assessable",
"scan": [],
"state": "no_data",
"status_text": "draft \u2014 requires clinical and coding review",
"supported": null,
"threshold": null,
"tier": "measured",
"values": [],
"variant": null,
"version": "1.0",
"window": {
"days": 730,
"from": "2024-11-13T21:55:00",
"n": 0,
"to": "2026-11-13T21:55:00"
},
"window_assessable": false,
"window_met": false
},
"note": {
"faults": [],
"spans": [],
"status": "silent"
},
"optional_set": null,
"priority": [
8,
3,
"diabetes"
],
"status_text": "draft \u2014 requires clinical and coding review",
"tier": "measured",
"topic": "Glucose and HbA1c",
"version": "1.0",
"why": "no measurement in the window"
},
{
"checks": [
"contradiction",
"not_stated"
],
"citation": null,
"contested": true,
"contested_note": "Other bodies (for example WHO) are understood to use a different impaired fasting glucose range and not to use an A1C prediabetes range; those texts were not opened, so no other thresholds are recorded. Review item.",
"definition": "ada2026_prediabetes@1.0",
"direction": "NOT_ASSESSED",
"draft": true,
"family": "prediabetes",
"family_order": 4,
"id": "ada2026_prediabetes",
"measurement": {
"adjustments": [],
"alternatives": [],
"any_history": false,
"category": null,
"category_label": null,
"clinician_label": null,
"condition_threshold": "intermediate range (HbA1c 5.7 to 6.4%, fasting glucose 100 to 125 mg/dL, or 2-hour glucose 140 to 199 mg/dL) (HbA1c \u2265 5.7 % and HbA1c < 6.5 % or fasting glucose \u2265 100 mg/dL and fasting glucose < 126 mg/dL or 2-hour glucose \u2265 140 mg/dL and 2-hour glucose < 200 mg/dL)",
"confirmation": null,
"contested": true,
"contested_note": "Other bodies (for example WHO) are understood to use a different impaired fasting glucose range and not to use an A1C prediabetes range; those texts were not opened, so no other thresholds are recorded. Review item.",
"definition": "ada2026_prediabetes@1.0",
"edition_current": true,
"family": "prediabetes",
"has_data": false,
"id": "ada2026_prediabetes",
"missing_context": [],
"notes": [],
"reason_code": "no_value",
"reasons": [
"needed to decide whether the definition applies: context 'pregnant' not provided"
],
"result": "not_assessable",
"scan": [],
"state": "no_data",
"status_text": "draft \u2014 requires clinical and coding review",
"supported": null,
"threshold": null,
"tier": "measured",
"values": [],
"variant": null,
"version": "1.0",
"window": {
"days": 365,
"from": "2025-11-13T21:55:00",
"n": 0,
"to": "2026-11-13T21:55:00"
},
"window_assessable": false,
"window_met": false
},
"note": {
"faults": [],
"spans": [],
"status": "silent"
},
"optional_set": null,
"priority": [
8,
4,
"prediabetes"
],
"status_text": "draft \u2014 requires clinical and coding review",
"tier": "measured",
"topic": "Glucose and HbA1c (intermediate range)",
"version": "1.0",
"why": "no measurement in the window"
},
{
"checks": [
"contradiction",
"not_stated"
],
"citation": null,
"contested": true,
"contested_note": "The International Hypoglycaemia Study Group (2017) sets level 1 at 'a glucose alert value of 3.9 mmol/l (70 mg/dl) or less', i.e. it includes exactly 70 mg/dL; ADA 2026 uses '<70'. CTCAE uses other cut-offs.",
"definition": "ada2026_hypoglycaemia@1.0",
"direction": "NOT_ASSESSED",
"draft": true,
"family": "hypoglycaemia",
"family_order": 5,
"id": "ada2026_hypoglycaemia",
"measurement": {
"adjustments": [],
"alternatives": [],
"any_history": false,
"category": null,
"category_label": null,
"clinician_label": null,
"condition_threshold": "level 3 (severe event needing assistance) (a recorded clinical item); level 2 (glucose below 54 mg/dL) (glucose < 54 mg/dL); level 1 (glucose 54 to below 70 mg/dL) (glucose \u2265 54 mg/dL and glucose < 70 mg/dL)",
"confirmation": null,
"contested": true,
"contested_note": "The International Hypoglycaemia Study Group (2017) sets level 1 at 'a glucose alert value of 3.9 mmol/l (70 mg/dl) or less', i.e. it includes exactly 70 mg/dL; ADA 2026 uses '<70'. CTCAE uses other cut-offs.",
"definition": "ada2026_hypoglycaemia@1.0",
"edition_current": true,
"family": "hypoglycaemia",
"has_data": false,
"id": "ada2026_hypoglycaemia",
"missing_context": [],
"notes": [],
"reason_code": "no_value",
"reasons": [
"needed to decide whether the definition applies: context 'has_diabetes' not provided"
],
"result": "not_assessable",
"scan": [],
"state": "no_data",
"status_text": "draft \u2014 requires clinical and coding review",
"supported": null,
"threshold": null,
"tier": "measured",
"values": [],
"variant": null,
"version": "1.0",
"window": {
"days": 14,
"from": "2026-10-30T21:55:00",
"n": 0,
"to": "2026-11-13T21:55:00"
},
"window_assessable": false,
"window_met": false
},
"note": {
"faults": [],
"spans": [],
"status": "silent"
},
"optional_set": null,
"priority": [
8,
5,
"hypoglycaemia"
],
"status_text": "draft \u2014 requires clinical and coding review",
"tier": "measured",
"topic": "Low glucose values",
"version": "1.0",
"why": "no measurement in the window"
},
{
"checks": [
"contradiction",
"not_stated"
],
"citation": null,
"contested": true,
"contested_note": "BMI cut-offs are population-specific (WHO 2004 expert consultation proposed lower action points for Asian populations; not opened) and BMI does not measure adiposity directly; the CDC page applies the categories 'regardless of age, sex, or race' for adults.",
"definition": "cdc_adult_bmi@1.0",
"direction": "NOT_ASSESSED",
"draft": true,
"family": "bmi",
"family_order": 6,
"id": "cdc_adult_bmi",
"measurement": {
"adjustments": [],
"alternatives": [
{
"category": null,
"category_label": null,
"clinician_label": null,
"definition": "who_adult_bmi@1.0",
"id": "who_adult_bmi",
"optional_set": null,
"reason_code": "no_value",
"reasons": [
"no usable bmi measurement"
],
"result": "not_assessable",
"version": "1.0"
}
],
"any_history": false,
"category": null,
"category_label": null,
"clinician_label": null,
"condition_threshold": "40 or more band (class 3) (body-mass index \u2265 40 kg/m2); 35 to below 40 band (class 2) (body-mass index \u2265 35 kg/m2 and body-mass index < 40 kg/m2); 30 to below 35 band (class 1) (body-mass index \u2265 30 kg/m2 and body-mass index < 35 kg/m2); 25 to below 30 band (body-mass index \u2265 25 kg/m2 and body-mass index < 30 kg/m2); below 18.5 band (body-mass index < 18.5 kg/m2)",
"confirmation": null,
"contested": true,
"contested_note": "BMI cut-offs are population-specific (WHO 2004 expert consultation proposed lower action points for Asian populations; not opened) and BMI does not measure adiposity directly; the CDC page applies the categories 'regardless of age, sex, or race' for adults.",
"definition": "cdc_adult_bmi@1.0",
"edition_current": true,
"family": "bmi",
"has_data": false,
"id": "cdc_adult_bmi",
"missing_context": [],
"notes": [],
"reason_code": "no_value",
"reasons": [
"no usable bmi measurement"
],
"result": "not_assessable",
"scan": [],
"state": "no_data",
"status_text": "draft \u2014 requires clinical and coding review",
"supported": null,
"threshold": null,
"tier": "measured",
"values": [],
"variant": null,
"version": "1.0",
"window": {
"days": 365,
"from": "2025-11-13T21:55:00",
"n": 0,
"to": "2026-11-13T21:55:00"
},
"window_assessable": false,
"window_met": false
},
"note": {
"faults": [],
"spans": [],
"status": "silent"
},
"optional_set": null,
"priority": [
8,
6,
"bmi"
],
"status_text": "draft \u2014 requires clinical and coding review",
"tier": "measured",
"topic": "Body-mass index",
"version": "1.0",
"why": "no measurement in the window"
},
{
"checks": [
"contradiction",
"not_stated"
],
"citation": null,
"contested": true,
"contested_note": "European guidelines define hypertension at 140/90 (ESC 2024, encoded separately as esc2024_office_bp) while AHA/ACC use 130/80.",
"definition": "nhlbi_bp_categories@1.0",
"direction": "NOT_ASSESSED",
"draft": true,
"family": "blood_pressure",
"family_order": 7,
"id": "nhlbi_bp_categories",
"measurement": {
"adjustments": [],
"alternatives": [
{
"category": null,
"category_label": null,
"clinician_label": null,
"definition": "esc2024_office_bp@1.0",
"id": "esc2024_office_bp",
"optional_set": null,
"reason_code": "no_value",
"reasons": [
"no reading with all of bp_systolic_office, bp_diastolic_office recorded at the same time",
"no usable bp_diastolic_office measurement",
"no usable bp_systolic_office measurement"
],
"result": "not_assessable",
"version": "1.0"
}
],
"any_history": false,
"category": null,
"category_label": null,
"clinician_label": null,
"condition_threshold": "range above 180 systolic or above 120 diastolic (systolic > 180 mmHg or diastolic > 120 mmHg); stage 2 range (140 or more systolic, or 90 or more diastolic) (systolic \u2265 140 mmHg or diastolic \u2265 90 mmHg); stage 1 range (130 to 139 systolic, or 80 to 89 diastolic) (systolic \u2265 130 mmHg and systolic < 140 mmHg or diastolic \u2265 80 mmHg and diastolic < 90 mmHg); elevated range (120 to 129 systolic and below 80 diastolic) (systolic \u2265 120 mmHg and systolic < 130 mmHg and diastolic < 80 mmHg)",
"confirmation": null,
"contested": true,
"contested_note": "European guidelines define hypertension at 140/90 (ESC 2024, encoded separately as esc2024_office_bp) while AHA/ACC use 130/80.",
"definition": "nhlbi_bp_categories@1.0",
"edition_current": true,
"family": "blood_pressure",
"has_data": false,
"id": "nhlbi_bp_categories",
"missing_context": [],
"notes": [],
"reason_code": "no_value",
"reasons": [
"no reading with all of bp_systolic_office, bp_diastolic_office recorded at the same time",
"no usable bp_diastolic_office measurement",
"no usable bp_systolic_office measurement"
],
"result": "not_assessable",
"scan": [],
"state": "no_data",
"status_text": "draft \u2014 requires clinical and coding review",
"supported": null,
"threshold": null,
"tier": "measured",
"values": [],
"variant": null,
"version": "1.0",
"window": {
"days": 365,
"from": "2025-11-13T21:55:00",
"n": 0,
"to": "2026-11-13T21:55:00"
},
"window_assessable": false,
"window_met": false
},
"note": {
"faults": [],
"spans": [],
"status": "silent"
},
"optional_set": null,
"priority": [
8,
7,
"blood_pressure"
],
"status_text": "draft \u2014 requires clinical and coding review",
"tier": "measured",
"topic": "Blood pressure readings",
"version": "1.0",
"why": "no measurement in the window"
},
{
"checks": [
"contradiction",
"not_stated"
],
"citation": null,
"contested": false,
"contested_note": "Same 190 mg/dL boundary as ATP III 'very high'.",
"definition": "aha2018_severe_hypercholesterolaemia@1.0",
"direction": "NOT_ASSESSED",
"draft": true,
"family": "ldl",
"family_order": 8,
"id": "aha2018_severe_hypercholesterolaemia",
"measurement": {
"adjustments": [],
"alternatives": [
{
"category": null,
"category_label": null,
"clinician_label": null,
"definition": "atp3_ldl@1.0",
"id": "atp3_ldl",
"optional_set": null,
"reason_code": "no_value",
"reasons": [
"no usable ldl_cholesterol measurement"
],
"result": "not_assessable",
"version": "1.0"
}
],
"any_history": false,
"category": null,
"category_label": null,
"clinician_label": null,
"condition_threshold": "LDL 190 mg/dL or more (LDL \u2265 190 mg/dL)",
"confirmation": null,
"contested": false,
"contested_note": "Same 190 mg/dL boundary as ATP III 'very high'.",
"definition": "aha2018_severe_hypercholesterolaemia@1.0",
"edition_current": true,
"family": "ldl",
"has_data": false,
"id": "aha2018_severe_hypercholesterolaemia",
"missing_context": [],
"notes": [],
"reason_code": "no_value",
"reasons": [
"no usable ldl_cholesterol measurement"
],
"result": "not_assessable",
"scan": [],
"state": "no_data",
"status_text": "draft \u2014 requires clinical and coding review",
"supported": null,
"threshold": null,
"tier": "measured",
"values": [],
"variant": null,
"version": "1.0",
"window": {
"days": 730,
"from": "2024-11-13T21:55:00",
"n": 0,
"to": "2026-11-13T21:55:00"
},
"window_assessable": false,
"window_met": false
},
"note": {
"faults": [],
"spans": [],
"status": "silent"
},
"optional_set": null,
"priority": [
8,
8,
"ldl"
],
"status_text": "draft \u2014 requires clinical and coding review",
"tier": "measured",
"topic": "LDL cholesterol",
"version": "1.0",
"why": "no measurement in the window"
},
{
"checks": [
"contradiction",
"not_stated"
],
"citation": null,
"contested": true,
"contested_note": "Ferritin cut-offs for iron deficiency vary widely between bodies and studies (the guideline's own review cites thresholds from <12 to <30 \u00b5g/L in pregnancy); WHO's are low (high specificity). Other bodies (e.g. gastroenterology guidance) use higher values; those texts were not opened.",
"definition": "who2020_iron_deficiency_ferritin@1.0",
"direction": "NOT_ASSESSED",
"draft": true,
"family": "ferritin",
"family_order": 9,
"id": "who2020_iron_deficiency_ferritin",
"measurement": {
"adjustments": [],
"alternatives": [],
"any_history": false,
"category": null,
"category_label": null,
"clinician_label": null,
"condition_threshold": "band below the ferritin cut-off for this group (ferritin < 15 ug/L)",
"confirmation": null,
"contested": true,
"contested_note": "Ferritin cut-offs for iron deficiency vary widely between bodies and studies (the guideline's own review cites thresholds from <12 to <30 \u00b5g/L in pregnancy); WHO's are low (high specificity). Other bodies (e.g. gastroenterology guidance) use higher values; those texts were not opened.",
"definition": "who2020_iron_deficiency_ferritin@1.0",
"edition_current": true,
"family": "ferritin",
"has_data": false,
"id": "who2020_iron_deficiency_ferritin",
"missing_context": [],
"notes": [],
"reason_code": "no_value",
"reasons": [
"no usable ferritin_serum measurement"
],
"result": "not_assessable",
"scan": [],
"state": "no_data",
"status_text": "draft \u2014 requires clinical and coding review",
"supported": null,
"threshold": null,
"tier": "measured",
"values": [],
"variant": null,
"version": "1.0",
"window": {
"days": 180,
"from": "2026-05-17T21:55:00",
"n": 0,
"to": "2026-11-13T21:55:00"
},
"window_assessable": false,
"window_met": false
},
"note": {
"faults": [],
"spans": [],
"status": "silent"
},
"optional_set": null,
"priority": [
8,
9,
"ferritin"
],
"status_text": "draft \u2014 requires clinical and coding review",
"tier": "measured",
"topic": "Ferritin",
"version": "1.0",
"why": "no measurement in the window"
},
{
"checks": [
"contradiction",
"not_stated"
],
"citation": null,
"contested": true,
"contested_note": "T-score categories were defined for postmenopausal (white) women; their use in men and other populations relies on later bodies (e.g. ISCD), which were not opened; the report itself calls cut-off values 'somewhat arbitrary'.",
"definition": "who1994_osteoporosis@1.0",
"direction": "NOT_ASSESSED",
"draft": true,
"family": "bone_density",
"family_order": 10,
"id": "who1994_osteoporosis",
"measurement": {
"adjustments": [],
"alternatives": [],
"any_history": false,
"category": null,
"category_label": null,
"clinician_label": null,
"condition_threshold": "T-score below -2.5 with a fragility fracture (T-score < -2.5 SD and a recorded clinical item); T-score -2.5 or lower band (T-score \u2264 -2.5 SD); T-score between -1 and -2.5 band (T-score > -2.5 SD and T-score < -1 SD)",
"confirmation": null,
"contested": true,
"contested_note": "T-score categories were defined for postmenopausal (white) women; their use in men and other populations relies on later bodies (e.g. ISCD), which were not opened; the report itself calls cut-off values 'somewhat arbitrary'.",
"definition": "who1994_osteoporosis@1.0",
"edition_current": null,
"family": "bone_density",
"has_data": false,
"id": "who1994_osteoporosis",
"missing_context": [],
"notes": [],
"reason_code": "no_value",
"reasons": [
"needed to decide whether the definition applies: context 'postmenopausal' not provided"
],
"result": "not_assessable",
"scan": [],
"state": "no_data",
"status_text": "draft \u2014 requires clinical and coding review",
"supported": null,
"threshold": null,
"tier": "measured",
"values": [],
"variant": null,
"version": "1.0",
"window": {
"days": 1095,
"from": "2023-11-14T21:55:00",
"n": 0,
"to": "2026-11-13T21:55:00"
},
"window_assessable": false,
"window_met": false
},
"note": {
"faults": [],
"spans": [],
"status": "silent"
},
"optional_set": null,
"priority": [
8,
10,
"bone_density"
],
"status_text": "draft \u2014 requires clinical and coding review",
"tier": "measured",
"topic": "Bone density T-score",
"version": "1.0",
"why": "no measurement in the window"
},
{
"checks": [
"judgement_tier"
],
"citation": null,
"contested": true,
"contested_note": "The fixed ratio 0.7 is contested against the lower limit of normal (z-score) approach used by ATS/ERS interpretation standards (not opened); the fixed ratio over-diagnoses in older and under-diagnoses in younger adults.",
"definition": "gold2026_copd_airflow@1.0",
"direction": "NOT_ASSESSED",
"draft": true,
"family": "copd_airflow",
"family_order": 11,
"id": "gold2026_copd_airflow",
"measurement": {
"adjustments": [],
"alternatives": [],
"any_history": false,
"category": null,
"category_label": null,
"clinician_label": null,
"condition_threshold": "FEV1/FVC below 0.7 with FEV1 below 30% predicted (grade 4) (FEV1/FVC < 0.7 and FEV1 % predicted < 30 %); FEV1/FVC below 0.7 with FEV1 30 to below 50% predicted (grade 3) (FEV1/FVC < 0.7 and FEV1 % predicted \u2265 30 % and FEV1 % predicted < 50 %); FEV1/FVC below 0.7 with FEV1 50 to below 80% predicted (grade 2) (FEV1/FVC < 0.7 and FEV1 % predicted \u2265 50 % and FEV1 % predicted < 80 %); FEV1/FVC below 0.7 with FEV1 80% predicted or more (grade 1) (FEV1/FVC < 0.7 and FEV1 % predicted \u2265 80 %)",
"confirmation": null,
"contested": true,
"contested_note": "The fixed ratio 0.7 is contested against the lower limit of normal (z-score) approach used by ATS/ERS interpretation standards (not opened); the fixed ratio over-diagnoses in older and under-diagnoses in younger adults.",
"definition": "gold2026_copd_airflow@1.0",
"edition_current": true,
"family": "copd_airflow",
"has_data": false,
"id": "gold2026_copd_airflow",
"missing_context": [],
"notes": [],
"reason_code": "no_value",
"reasons": [
"no reading with all of fev1_fvc_ratio_post_bd, fev1_pct_predicted_post_bd recorded at the same time",
"no usable fev1_fvc_ratio_post_bd measurement",
"no usable fev1_pct_predicted_post_bd measurement"
],
"result": "not_assessable",
"scan": [],
"state": "no_data",
"status_text": "draft \u2014 requires clinical and coding review",
"supported": null,
"threshold": null,
"tier": "judgement",
"values": [],
"variant": null,
"version": "1.0",
"window": {
"days": 1095,
"from": "2023-11-14T21:55:00",
"n": 0,
"to": "2026-11-13T21:55:00"
},
"window_assessable": false,
"window_met": false
},
"note": {
"faults": [],
"spans": [],
"status": "silent"
},
"optional_set": null,
"priority": [
8,
11,
"copd_airflow"
],
"status_text": "draft \u2014 requires clinical and coding review",
"tier": "judgement",
"topic": "Lung function after bronchodilator",
"version": "1.0",
"why": ""
},
{
"checks": [
"judgement_tier"
],
"citation": null,
"contested": false,
"contested_note": "The same cut-offs appear in the co-published Eur J Heart Fail and J Card Fail versions; some guidelines describe HFmrEF differently in wording only (not opened).",
"definition": "uhf2021_hf_ef_category@1.0",
"direction": "NOT_ASSESSED",
"draft": true,
"family": "heart_failure_ef",
"family_order": 12,
"id": "uhf2021_hf_ef_category",
"measurement": {
"adjustments": [],
"alternatives": [],
"any_history": false,
"category": null,
"category_label": null,
"clinician_label": null,
"condition_threshold": "improved category (from 40% or below to above 40%, a rise of 10 points or more) (earliest ejection fraction \u2264 40 % and ejection fraction > 40 % and change in ejection fraction \u2265 10); 40% or below (ejection fraction \u2264 40 %); 41 to 49% (ejection fraction > 40 % and ejection fraction < 50 %); 50% or above (ejection fraction \u2265 50 %)",
"confirmation": null,
"contested": false,
"contested_note": "The same cut-offs appear in the co-published Eur J Heart Fail and J Card Fail versions; some guidelines describe HFmrEF differently in wording only (not opened).",
"definition": "uhf2021_hf_ef_category@1.0",
"edition_current": null,
"family": "heart_failure_ef",
"has_data": false,
"id": "uhf2021_hf_ef_category",
"missing_context": [],
"notes": [],
"reason_code": "no_value",
"reasons": [
"needed to decide whether the definition applies: context 'heart_failure' not provided"
],
"result": "not_assessable",
"scan": [],
"state": "no_data",
"status_text": "draft \u2014 requires clinical and coding review",
"supported": null,
"threshold": null,
"tier": "judgement",
"values": [],
"variant": null,
"version": "1.0",
"window": {
"days": 730,
"from": "2024-11-13T21:55:00",
"n": 0,
"to": "2026-11-13T21:55:00"
},
"window_assessable": false,
"window_met": false
},
"note": {
"faults": [],
"spans": [],
"status": "silent"
},
"optional_set": null,
"priority": [
8,
12,
"heart_failure_ef"
],
"status_text": "draft \u2014 requires clinical and coding review",
"tier": "judgement",
"topic": "Ejection fraction",
"version": "1.0",
"why": ""
},
{
"checks": [
"judgement_tier"
],
"citation": null,
"contested": false,
"contested_note": "Bands unchanged from Berlin for intubated patients.",
"definition": "global2024_ards_intubated_pf@1.0",
"direction": "NOT_ASSESSED",
"draft": true,
"family": "oxygenation",
"family_order": 14,
"id": "global2024_ards_intubated_pf",
"measurement": {
"adjustments": [],
"alternatives": [
{
"category": null,
"category_label": null,
"clinician_label": null,
"definition": "berlin2012_ards_pf@1.0",
"id": "berlin2012_ards_pf",
"optional_set": null,
"reason_code": "no_value",
"reasons": [
"no reading with all of pao2, fio2 recorded at the same time",
"no usable fio2 measurement",
"no usable pao2 measurement"
],
"result": "not_assessable",
"version": "1.0"
}
],
"any_history": false,
"category": null,
"category_label": null,
"clinician_label": null,
"condition_threshold": "PaO2/FiO2 \u2264 100; PaO2/FiO2 > 100 and PaO2/FiO2 \u2264 200; PaO2/FiO2 > 200 and PaO2/FiO2 \u2264 300",
"confirmation": null,
"contested": false,
"contested_note": "Bands unchanged from Berlin for intubated patients.",
"definition": "global2024_ards_intubated_pf@1.0",
"edition_current": true,
"family": "oxygenation",
"has_data": false,
"id": "global2024_ards_intubated_pf",
"missing_context": [],
"notes": [],
"reason_code": "no_value",
"reasons": [
"needed to decide whether the definition applies: context 'intubated' not provided"
],
"result": "not_assessable",
"scan": [],
"state": "no_data",
"status_text": "draft \u2014 requires clinical and coding review",
"supported": null,
"threshold": null,
"tier": "judgement",
"values": [],
"variant": null,
"version": "1.0",
"window": {
"days": 7,
"from": "2026-11-06T21:55:00",
"n": 0,
"to": "2026-11-13T21:55:00"
},
"window_assessable": false,
"window_met": false
},
"note": {
"faults": [],
"spans": [],
"status": "silent"
},
"optional_set": null,
"priority": [
8,
14,
"oxygenation"
],
"status_text": "draft \u2014 requires clinical and coding review",
"tier": "judgement",
"topic": "Oxygenation (PaO2/FiO2)",
"version": "1.0",
"why": ""
}
],
"measurement": {
"config": "library_default_set@1.0",
"context_used": {
"age_years": 75,
"sex": "female"
},
"engine": "library-engine 1.0",
"families": {
"blood_pressure": {
"adjustments": [],
"alternatives": [
{
"category": null,
"category_label": null,
"clinician_label": null,
"definition": "esc2024_office_bp@1.0",
"id": "esc2024_office_bp",
"optional_set": null,
"reason_code": "no_value",
"reasons": [
"no reading with all of bp_systolic_office, bp_diastolic_office recorded at the same time",
"no usable bp_diastolic_office measurement",
"no usable bp_systolic_office measurement"
],
"result": "not_assessable",
"version": "1.0"
}
],
"any_history": false,
"category": null,
"category_label": null,
"clinician_label": null,
"condition_threshold": "range above 180 systolic or above 120 diastolic (systolic > 180 mmHg or diastolic > 120 mmHg); stage 2 range (140 or more systolic, or 90 or more diastolic) (systolic \u2265 140 mmHg or diastolic \u2265 90 mmHg); stage 1 range (130 to 139 systolic, or 80 to 89 diastolic) (systolic \u2265 130 mmHg and systolic < 140 mmHg or diastolic \u2265 80 mmHg and diastolic < 90 mmHg); elevated range (120 to 129 systolic and below 80 diastolic) (systolic \u2265 120 mmHg and systolic < 130 mmHg and diastolic < 80 mmHg)",
"confirmation": null,
"contested": true,
"contested_note": "European guidelines define hypertension at 140/90 (ESC 2024, encoded separately as esc2024_office_bp) while AHA/ACC use 130/80.",
"definition": "nhlbi_bp_categories@1.0",
"edition_current": true,
"family": "blood_pressure",
"has_data": false,
"id": "nhlbi_bp_categories",
"missing_context": [],
"notes": [],
"reason_code": "no_value",
"reasons": [
"no reading with all of bp_systolic_office, bp_diastolic_office recorded at the same time",
"no usable bp_diastolic_office measurement",
"no usable bp_systolic_office measurement"
],
"result": "not_assessable",
"scan": [],
"state": "no_data",
"status_text": "draft \u2014 requires clinical and coding review",
"supported": null,
"threshold": null,
"tier": "measured",
"values": [],
"variant": null,
"version": "1.0",
"window": {
"days": 365,
"from": "2025-11-13T21:55:00",
"n": 0,
"to": "2026-11-13T21:55:00"
},
"window_assessable": false,
"window_met": false
},
"bmi": {
"adjustments": [],
"alternatives": [
{
"category": null,
"category_label": null,
"clinician_label": null,
"definition": "who_adult_bmi@1.0",
"id": "who_adult_bmi",
"optional_set": null,
"reason_code": "no_value",
"reasons": [
"no usable bmi measurement"
],
"result": "not_assessable",
"version": "1.0"
}
],
"any_history": false,
"category": null,
"category_label": null,
"clinician_label": null,
"condition_threshold": "40 or more band (class 3) (body-mass index \u2265 40 kg/m2); 35 to below 40 band (class 2) (body-mass index \u2265 35 kg/m2 and body-mass index < 40 kg/m2); 30 to below 35 band (class 1) (body-mass index \u2265 30 kg/m2 and body-mass index < 35 kg/m2); 25 to below 30 band (body-mass index \u2265 25 kg/m2 and body-mass index < 30 kg/m2); below 18.5 band (body-mass index < 18.5 kg/m2)",
"confirmation": null,
"contested": true,
"contested_note": "BMI cut-offs are population-specific (WHO 2004 expert consultation proposed lower action points for Asian populations; not opened) and BMI does not measure adiposity directly; the CDC page applies the categories 'regardless of age, sex, or race' for adults.",
"definition": "cdc_adult_bmi@1.0",
"edition_current": true,
"family": "bmi",
"has_data": false,
"id": "cdc_adult_bmi",
"missing_context": [],
"notes": [],
"reason_code": "no_value",
"reasons": [
"no usable bmi measurement"
],
"result": "not_assessable",
"scan": [],
"state": "no_data",
"status_text": "draft \u2014 requires clinical and coding review",
"supported": null,
"threshold": null,
"tier": "measured",
"values": [],
"variant": null,
"version": "1.0",
"window": {
"days": 365,
"from": "2025-11-13T21:55:00",
"n": 0,
"to": "2026-11-13T21:55:00"
},
"window_assessable": false,
"window_met": false
},
"bone_density": {
"adjustments": [],
"alternatives": [],
"any_history": false,
"category": null,
"category_label": null,
"clinician_label": null,
"condition_threshold": "T-score below -2.5 with a fragility fracture (T-score < -2.5 SD and a recorded clinical item); T-score -2.5 or lower band (T-score \u2264 -2.5 SD); T-score between -1 and -2.5 band (T-score > -2.5 SD and T-score < -1 SD)",
"confirmation": null,
"contested": true,
"contested_note": "T-score categories were defined for postmenopausal (white) women; their use in men and other populations relies on later bodies (e.g. ISCD), which were not opened; the report itself calls cut-off values 'somewhat arbitrary'.",
"definition": "who1994_osteoporosis@1.0",
"edition_current": null,
"family": "bone_density",
"has_data": false,
"id": "who1994_osteoporosis",
"missing_context": [],
"notes": [],
"reason_code": "no_value",
"reasons": [
"needed to decide whether the definition applies: context 'postmenopausal' not provided"
],
"result": "not_assessable",
"scan": [],
"state": "no_data",
"status_text": "draft \u2014 requires clinical and coding review",
"supported": null,
"threshold": null,
"tier": "measured",
"values": [],
"variant": null,
"version": "1.0",
"window": {
"days": 1095,
"from": "2023-11-14T21:55:00",
"n": 0,
"to": "2026-11-13T21:55:00"
},
"window_assessable": false,
"window_met": false
},
"copd_airflow": {
"adjustments": [],
"alternatives": [],
"any_history": false,
"category": null,
"category_label": null,
"clinician_label": null,
"condition_threshold": "FEV1/FVC below 0.7 with FEV1 below 30% predicted (grade 4) (FEV1/FVC < 0.7 and FEV1 % predicted < 30 %); FEV1/FVC below 0.7 with FEV1 30 to below 50% predicted (grade 3) (FEV1/FVC < 0.7 and FEV1 % predicted \u2265 30 % and FEV1 % predicted < 50 %); FEV1/FVC below 0.7 with FEV1 50 to below 80% predicted (grade 2) (FEV1/FVC < 0.7 and FEV1 % predicted \u2265 50 % and FEV1 % predicted < 80 %); FEV1/FVC below 0.7 with FEV1 80% predicted or more (grade 1) (FEV1/FVC < 0.7 and FEV1 % predicted \u2265 80 %)",
"confirmation": null,
"contested": true,
"contested_note": "The fixed ratio 0.7 is contested against the lower limit of normal (z-score) approach used by ATS/ERS interpretation standards (not opened); the fixed ratio over-diagnoses in older and under-diagnoses in younger adults.",
"definition": "gold2026_copd_airflow@1.0",
"edition_current": true,
"family": "copd_airflow",
"has_data": false,
"id": "gold2026_copd_airflow",
"missing_context": [],
"notes": [],
"reason_code": "no_value",
"reasons": [
"no reading with all of fev1_fvc_ratio_post_bd, fev1_pct_predicted_post_bd recorded at the same time",
"no usable fev1_fvc_ratio_post_bd measurement",
"no usable fev1_pct_predicted_post_bd measurement"
],
"result": "not_assessable",
"scan": [],
"state": "no_data",
"status_text": "draft \u2014 requires clinical and coding review",
"supported": null,
"threshold": null,
"tier": "judgement",
"values": [],
"variant": null,
"version": "1.0",
"window": {
"days": 1095,
"from": "2023-11-14T21:55:00",
"n": 0,
"to": "2026-11-13T21:55:00"
},
"window_assessable": false,
"window_met": false
},
"diabetes": {
"adjustments": [],
"alternatives": [],
"any_history": false,
"category": null,
"category_label": null,
"clinician_label": null,
"condition_threshold": "two results at or above the diagnostic thresholds (number of qualifying results \u2265 2); random glucose 200 mg/dL or more with typical symptoms (random glucose \u2265 200 mg/dL and a recorded clinical item); one result at or above a diagnostic threshold (number of qualifying results \u2265 1)",
"confirmation": null,
"contested": false,
"contested_note": "ADA thresholds match long-standing WHO thresholds for A1C and FPG, but WHO's current text was not opened; the A1C criterion is less sensitive in some populations (ADA text).",
"definition": "ada2026_diabetes@1.0",
"edition_current": true,
"family": "diabetes",
"has_data": false,
"id": "ada2026_diabetes",
"missing_context": [],
"notes": [],
"reason_code": "no_value",
"reasons": [
"needed to decide whether the definition applies: context 'pregnant' not provided"
],
"result": "not_assessable",
"scan": [],
"state": "no_data",
"status_text": "draft \u2014 requires clinical and coding review",
"supported": null,
"threshold": null,
"tier": "measured",
"values": [],
"variant": null,
"version": "1.0",
"window": {
"days": 730,
"from": "2024-11-13T21:55:00",
"n": 0,
"to": "2026-11-13T21:55:00"
},
"window_assessable": false,
"window_met": false
},
"ferritin": {
"adjustments": [],
"alternatives": [],
"any_history": false,
"category": null,
"category_label": null,
"clinician_label": null,
"condition_threshold": "band below the ferritin cut-off for this group (ferritin < 15 ug/L)",
"confirmation": null,
"contested": true,
"contested_note": "Ferritin cut-offs for iron deficiency vary widely between bodies and studies (the guideline's own review cites thresholds from <12 to <30 \u00b5g/L in pregnancy); WHO's are low (high specificity). Other bodies (e.g. gastroenterology guidance) use higher values; those texts were not opened.",
"definition": "who2020_iron_deficiency_ferritin@1.0",
"edition_current": true,
"family": "ferritin",
"has_data": false,
"id": "who2020_iron_deficiency_ferritin",
"missing_context": [],
"notes": [],
"reason_code": "no_value",
"reasons": [
"no usable ferritin_serum measurement"
],
"result": "not_assessable",
"scan": [],
"state": "no_data",
"status_text": "draft \u2014 requires clinical and coding review",
"supported": null,
"threshold": null,
"tier": "measured",
"values": [],
"variant": null,
"version": "1.0",
"window": {
"days": 180,
"from": "2026-05-17T21:55:00",
"n": 0,
"to": "2026-11-13T21:55:00"
},
"window_assessable": false,
"window_met": false
},
"haemoglobin": {
"adjustments": [],
"alternatives": [],
"any_history": false,
"category": null,
"category_label": null,
"clinician_label": null,
"condition_threshold": "'severe' band (haemoglobin < 70 g/L); 'moderate' band (haemoglobin \u2265 70 g/L and haemoglobin < 100 g/L); 'mild' band (haemoglobin \u2265 100 g/L and haemoglobin < 110 g/L)",
"confirmation": null,
"contested": true,
"contested_note": "Cut-offs are 5th percentiles of mostly higher-income populations (WHO's own remark); the men's 130 g/L cut-off and severity percentages were debated by the guideline group; CTCAE and laboratory reference ranges use other limits; older adults (>65) are not covered.",
"definition": "who2024_anaemia@1.0",
"edition_current": true,
"family": "haemoglobin",
"has_data": false,
"id": "who2024_anaemia",
"missing_context": [],
"notes": [],
"reason_code": "no_value",
"reasons": [
"outside the population the source defines: individuals aged 6 months to 65 years (Table 2 covers no other ages); pregnancy by trimester"
],
"result": "not_assessable",
"scan": [],
"state": "no_data",
"status_text": "draft \u2014 requires clinical and coding review",
"supported": null,
"threshold": null,
"tier": "measured",
"values": [],
"variant": null,
"version": "1.0",
"window": {
"days": 30,
"from": "2026-10-14T21:55:00",
"n": 0,
"to": "2026-11-13T21:55:00"
},
"window_assessable": false,
"window_met": false
},
"heart_failure_ef": {
"adjustments": [],
"alternatives": [],
"any_history": false,
"category": null,
"category_label": null,
"clinician_label": null,
"condition_threshold": "improved category (from 40% or below to above 40%, a rise of 10 points or more) (earliest ejection fraction \u2264 40 % and ejection fraction > 40 % and change in ejection fraction \u2265 10); 40% or below (ejection fraction \u2264 40 %); 41 to 49% (ejection fraction > 40 % and ejection fraction < 50 %); 50% or above (ejection fraction \u2265 50 %)",
"confirmation": null,
"contested": false,
"contested_note": "The same cut-offs appear in the co-published Eur J Heart Fail and J Card Fail versions; some guidelines describe HFmrEF differently in wording only (not opened).",
"definition": "uhf2021_hf_ef_category@1.0",
"edition_current": null,
"family": "heart_failure_ef",
"has_data": false,
"id": "uhf2021_hf_ef_category",
"missing_context": [],
"notes": [],
"reason_code": "no_value",
"reasons": [
"needed to decide whether the definition applies: context 'heart_failure' not provided"
],
"result": "not_assessable",
"scan": [],
"state": "no_data",
"status_text": "draft \u2014 requires clinical and coding review",
"supported": null,
"threshold": null,
"tier": "judgement",
"values": [],
"variant": null,
"version": "1.0",
"window": {
"days": 730,
"from": "2024-11-13T21:55:00",
"n": 0,
"to": "2026-11-13T21:55:00"
},
"window_assessable": false,
"window_met": false
},
"hypoglycaemia": {
"adjustments": [],
"alternatives": [],
"any_history": false,
"category": null,
"category_label": null,
"clinician_label": null,
"condition_threshold": "level 3 (severe event needing assistance) (a recorded clinical item); level 2 (glucose below 54 mg/dL) (glucose < 54 mg/dL); level 1 (glucose 54 to below 70 mg/dL) (glucose \u2265 54 mg/dL and glucose < 70 mg/dL)",
"confirmation": null,
"contested": true,
"contested_note": "The International Hypoglycaemia Study Group (2017) sets level 1 at 'a glucose alert value of 3.9 mmol/l (70 mg/dl) or less', i.e. it includes exactly 70 mg/dL; ADA 2026 uses '<70'. CTCAE uses other cut-offs.",
"definition": "ada2026_hypoglycaemia@1.0",
"edition_current": true,
"family": "hypoglycaemia",
"has_data": false,
"id": "ada2026_hypoglycaemia",
"missing_context": [],
"notes": [],
"reason_code": "no_value",
"reasons": [
"needed to decide whether the definition applies: context 'has_diabetes' not provided"
],
"result": "not_assessable",
"scan": [],
"state": "no_data",
"status_text": "draft \u2014 requires clinical and coding review",
"supported": null,
"threshold": null,
"tier": "measured",
"values": [],
"variant": null,
"version": "1.0",
"window": {
"days": 14,
"from": "2026-10-30T21:55:00",
"n": 0,
"to": "2026-11-13T21:55:00"
},
"window_assessable": false,
"window_met": false
},
"lactate": {
"adjustments": [],
"alternatives": [],
"any_history": true,
"category": "above",
"category_label": "Lactate >2 mmol/L (18 mg/dL): the Sepsis-3 septic-shock lactate criterion is met",
"clinician_label": "lactate above 2 mmol/L",
"condition_threshold": "lactate above 2 mmol/L (lactate > 2 mmol/L)",
"confirmation": null,
"contested": false,
"contested_note": "The CMS SEP-1 measure and the Surviving Sepsis Campaign use lactate thresholds for other purposes (for example \u22654 mmol/L); those documents were not opened for this entry.",
"definition": "sepsis3_septic_shock_lactate@1.0",
"edition_current": true,
"family": "lactate",
"has_data": true,
"id": "sepsis3_septic_shock_lactate",
"missing_context": [],
"notes": [],
"reason_code": null,
"reasons": [],
"result": "met",
"scan": [
{
"category": "above",
"confirmed": true,
"result": "met",
"time": "2026-11-11T15:10:00-05:00",
"values": [
{
"analyte": "lactate_serum",
"measurement_id": "LM-P15-03",
"time": "2026-11-11T15:10:00-05:00",
"unit": "mmol/L",
"value": 2.6
}
]
}
],
"state": "met",
"status_text": "draft \u2014 requires clinical and coding review",
"supported": {
"category": "above",
"earlier": false,
"time": "2026-11-13T16:55:00-05:00",
"values": [
{
"analyte": "lactate_serum",
"measurement_id": "LM-P15-03",
"time": "2026-11-11T15:10:00-05:00",
"unit": "mmol/L",
"value": 2.6
}
]
},
"threshold": "lactate > 2 mmol/L",
"tier": "judgement",
"values": [
{
"analyte": "lactate_serum",
"measurement_id": "LM-P15-03",
"time": "2026-11-11T15:10:00-05:00",
"unit": "mmol/L",
"value": 2.6
}
],
"variant": "all",
"version": "1.0",
"window": {
"days": 7,
"from": "2026-11-06T21:55:00",
"n": 1,
"to": "2026-11-13T21:55:00"
},
"window_assessable": true,
"window_met": true
},
"ldl": {
"adjustments": [],
"alternatives": [
{
"category": null,
"category_label": null,
"clinician_label": null,
"definition": "atp3_ldl@1.0",
"id": "atp3_ldl",
"optional_set": null,
"reason_code": "no_value",
"reasons": [
"no usable ldl_cholesterol measurement"
],
"result": "not_assessable",
"version": "1.0"
}
],
"any_history": false,
"category": null,
"category_label": null,
"clinician_label": null,
"condition_threshold": "LDL 190 mg/dL or more (LDL \u2265 190 mg/dL)",
"confirmation": null,
"contested": false,
"contested_note": "Same 190 mg/dL boundary as ATP III 'very high'.",
"definition": "aha2018_severe_hypercholesterolaemia@1.0",
"edition_current": true,
"family": "ldl",
"has_data": false,
"id": "aha2018_severe_hypercholesterolaemia",
"missing_context": [],
"notes": [],
"reason_code": "no_value",
"reasons": [
"no usable ldl_cholesterol measurement"
],
"result": "not_assessable",
"scan": [],
"state": "no_data",
"status_text": "draft \u2014 requires clinical and coding review",
"supported": null,
"threshold": null,
"tier": "measured",
"values": [],
"variant": null,
"version": "1.0",
"window": {
"days": 730,
"from": "2024-11-13T21:55:00",
"n": 0,
"to": "2026-11-13T21:55:00"
},
"window_assessable": false,
"window_met": false
},
"oxygenation": {
"adjustments": [],
"alternatives": [
{
"category": null,
"category_label": null,
"clinician_label": null,
"definition": "berlin2012_ards_pf@1.0",
"id": "berlin2012_ards_pf",
"optional_set": null,
"reason_code": "no_value",
"reasons": [
"no reading with all of pao2, fio2 recorded at the same time",
"no usable fio2 measurement",
"no usable pao2 measurement"
],
"result": "not_assessable",
"version": "1.0"
}
],
"any_history": false,
"category": null,
"category_label": null,
"clinician_label": null,
"condition_threshold": "PaO2/FiO2 \u2264 100; PaO2/FiO2 > 100 and PaO2/FiO2 \u2264 200; PaO2/FiO2 > 200 and PaO2/FiO2 \u2264 300",
"confirmation": null,
"contested": false,
"contested_note": "Bands unchanged from Berlin for intubated patients.",
"definition": "global2024_ards_intubated_pf@1.0",
"edition_current": true,
"family": "oxygenation",
"has_data": false,
"id": "global2024_ards_intubated_pf",
"missing_context": [],
"notes": [],
"reason_code": "no_value",
"reasons": [
"needed to decide whether the definition applies: context 'intubated' not provided"
],
"result": "not_assessable",
"scan": [],
"state": "no_data",
"status_text": "draft \u2014 requires clinical and coding review",
"supported": null,
"threshold": null,
"tier": "judgement",
"values": [],
"variant": null,
"version": "1.0",
"window": {
"days": 7,
"from": "2026-11-06T21:55:00",
"n": 0,
"to": "2026-11-13T21:55:00"
},
"window_assessable": false,
"window_met": false
},
"potassium": {
"adjustments": [],
"alternatives": [],
"any_history": true,
"category": "mild",
"category_label": "Mild hyperkalaemia (5.5\u20135.9 mmol/L)",
"clinician_label": "'mild' band (5.5 to 5.9 mmol/L)",
"condition_threshold": "'severe' band (6.5 mmol/L or more) (potassium \u2265 6.5 mmol/L); 'moderate' band (6.0 to 6.4 mmol/L) (potassium \u2265 6 mmol/L and potassium < 6.5 mmol/L); 'mild' band (5.5 to 5.9 mmol/L) (potassium \u2265 5.5 mmol/L and potassium < 6 mmol/L)",
"confirmation": null,
"contested": true,
"contested_note": "The guideline itself says 'There is no universally accepted definition of hyperkalaemia'; it adopts the ERC threshold of 5.5 mmol/L. CTCAE grades differ (see ctcae6_hyperkalaemia).",
"definition": "ukka2026_hyperkalaemia@1.0",
"edition_current": true,
"family": "potassium",
"has_data": true,
"id": "ukka2026_hyperkalaemia",
"missing_context": [],
"notes": [],
"reason_code": null,
"reasons": [],
"result": "met",
"scan": [
{
"category": "below_threshold",
"confirmed": true,
"result": "criteria_not_met",
"time": "2026-11-11T15:00:00-05:00",
"values": [
{
"analyte": "potassium_serum",
"measurement_id": "LM-P15-01",
"time": "2026-11-11T15:00:00-05:00",
"unit": "mmol/L",
"value": 5.1
}
]
},
{
"category": "mild",
"confirmed": true,
"result": "met",
"time": "2026-11-12T15:00:00-05:00",
"values": [
{
"analyte": "potassium_serum",
"measurement_id": "LM-P15-02",
"time": "2026-11-12T15:00:00-05:00",
"unit": "mmol/L",
"value": 5.8
}
]
}
],
"state": "met",
"status_text": "draft \u2014 requires clinical and coding review",
"supported": {
"category": "mild",
"earlier": false,
"time": "2026-11-13T16:55:00-05:00",
"values": [
{
"analyte": "potassium_serum",
"measurement_id": "LM-P15-02",
"time": "2026-11-12T15:00:00-05:00",
"unit": "mmol/L",
"value": 5.8
}
]
},
"threshold": "potassium \u2265 5.5 mmol/L and potassium < 6 mmol/L",
"tier": "measured",
"values": [
{
"analyte": "potassium_serum",
"measurement_id": "LM-P15-02",
"time": "2026-11-12T15:00:00-05:00",
"unit": "mmol/L",
"value": 5.8
}
],
"variant": "all",
"version": "1.0",
"window": {
"days": 14,
"from": "2026-10-30T21:55:00",
"n": 2,
"to": "2026-11-13T21:55:00"
},
"window_assessable": true,
"window_met": true
},
"prediabetes": {
"adjustments": [],
"alternatives": [],
"any_history": false,
"category": null,
"category_label": null,
"clinician_label": null,
"condition_threshold": "intermediate range (HbA1c 5.7 to 6.4%, fasting glucose 100 to 125 mg/dL, or 2-hour glucose 140 to 199 mg/dL) (HbA1c \u2265 5.7 % and HbA1c < 6.5 % or fasting glucose \u2265 100 mg/dL and fasting glucose < 126 mg/dL or 2-hour glucose \u2265 140 mg/dL and 2-hour glucose < 200 mg/dL)",
"confirmation": null,
"contested": true,
"contested_note": "Other bodies (for example WHO) are understood to use a different impaired fasting glucose range and not to use an A1C prediabetes range; those texts were not opened, so no other thresholds are recorded. Review item.",
"definition": "ada2026_prediabetes@1.0",
"edition_current": true,
"family": "prediabetes",
"has_data": false,
"id": "ada2026_prediabetes",
"missing_context": [],
"notes": [],
"reason_code": "no_value",
"reasons": [
"needed to decide whether the definition applies: context 'pregnant' not provided"
],
"result": "not_assessable",
"scan": [],
"state": "no_data",
"status_text": "draft \u2014 requires clinical and coding review",
"supported": null,
"threshold": null,
"tier": "measured",
"values": [],
"variant": null,
"version": "1.0",
"window": {
"days": 365,
"from": "2025-11-13T21:55:00",
"n": 0,
"to": "2026-11-13T21:55:00"
},
"window_assessable": false,
"window_met": false
},
"sodium": {
"adjustments": [],
"alternatives": [],
"any_history": false,
"category": null,
"category_label": null,
"clinician_label": null,
"condition_threshold": "below 135 mmol/L (sodium < 135 mmol/L)",
"confirmation": null,
"contested": false,
"contested_note": "The <135 mmol/L definition is widely shared; CTCAE uses the laboratory LLN instead.",
"definition": "ese2014_hyponatraemia@1.0",
"edition_current": null,
"family": "sodium",
"has_data": false,
"id": "ese2014_hyponatraemia",
"missing_context": [],
"notes": [],
"reason_code": "no_value",
"reasons": [
"no usable sodium_serum measurement"
],
"result": "not_assessable",
"scan": [],
"state": "no_data",
"status_text": "draft \u2014 requires clinical and coding review",
"supported": null,
"threshold": null,
"tier": "measured",
"values": [],
"variant": null,
"version": "1.0",
"window": {
"days": 14,
"from": "2026-10-30T21:55:00",
"n": 0,
"to": "2026-11-13T21:55:00"
},
"window_assessable": false,
"window_met": false
}
}
},
"measurement_sha256": "4efaaa60c76822f583ef516021d1b2699d1464f93fb6ffeb3f4f70b12431c090",
"reader": {
"lexicon": "library-lexicon 1.0",
"model_status": "ok",
"reader": "lexicon+model"
}
}